# Windward Bio funding rounds and investors

Windward Bio develops ultra-long-acting monoclonal antibodies for the treatment of serious respiratory and dermatologic diseases, targeting conditions like asthma and COPD.

Website: https://windwardbio.com  
Page: https://fireround.dev/companies/windwardbio.com

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.